Pharmacy first
Pharmacy first. Pharmacy deepest. Pharmacy only.
Every generalist FWA platform has a pharmacy module. None of them have a pharmacy product. We do.
Pharmacy claims are the hardest category in fraud detection. Substitution economics, cumulative-dose math, counterfeit exposure, schemes that mutate faster than rules can be rewritten. Generalist tools treat pharmacy as the last module. We treat it as the only one.
Why the hardest category is pharmacy
Pharmacy claims carry constraints that medical claims do not. Every dispensation has a substitution tree, a cumulative-dose ceiling, a peer-comparison baseline, and a counterfeit risk tied to the specific molecule and packaging. A clinical mismatch on pharmacy is not wrong code — it is wrong drug for the diagnosis the physician did not document. Rules mutate. Schemes mutate faster. The distance between flagging obvious fraud and catching the subtle waste a trained pharmacist would miss is where most platforms stop. It is where we start.
What depth looks like in practice
25 detection rules, built for pharmacy claims and nothing else. Same-molecule re-authorization. Cloned prescriptions. Cumulative dose against therapeutic ceilings. Generic substitution intelligence across brand trees. Early refill tuned to plan rules, not a generic lookback. Clinical mismatch against diagnosis codes. Each rule is a specialist — and the set composes into coverage that a generalist platform's pharmacy module cannot match, because depth is not a feature you add last.
What a pharmacy module cannot do
A pharmacy module inside a general-purpose FWA platform is a translation of medical-claim logic into pharmacy context. It catches what looks like fraud from a medical-claim distance. It misses the substitution economics that Mexican pharmacy chains have been exploiting for a decade. It misses the cumulative-dose edge cases a clinical pharmacist would notice instantly. It misses WAFL's Lack of Knowledge category entirely — the clinically wrong approvals no one flagged because no one coded for approver did not know the guideline.
What Pharmacy First means for your roadmap
It means every detection technique we add is measured on pharmacy claims, not borrowed from another category. It means the three-week proof of concept produces numbers on your actual book, not a projection from someone else's industry average. It means when counterfeit Mounjaro starts moving through Brazilian compounding pharmacies, the response is in our weekly release, not scheduled for the next platform refresh. Pharmacy first is a scope decision. It is also a speed decision.
pharmacy-specific detection rules running in production on real Latin American claims
Move from module to product
A three-week proof of concept on your real pharmacy data. No integration required.